These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 30556836)

  • 21. A neglected issue in interpretation of results of randomized controlled trials: informative censoring.
    Gorouhi F; Khatami A; Davari P
    Dermatol Online J; 2009 Jan; 15(1):13. PubMed ID: 19281718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Understanding the Intention-to-treat Principle in Randomized Controlled Trials.
    McCoy CE
    West J Emerg Med; 2017 Oct; 18(6):1075-1078. PubMed ID: 29085540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intention-to-treat or efficacy analysis?
    Horne D
    Br J Gen Pract; 2003 Apr; 53(489):324; author reply 324-5. PubMed ID: 12879836
    [No Abstract]   [Full Text] [Related]  

  • 24. Per-Protocol Analyses of Pragmatic Trials.
    Hernán MA; Robins JM
    N Engl J Med; 2017 Oct; 377(14):1391-1398. PubMed ID: 28976864
    [No Abstract]   [Full Text] [Related]  

  • 25. Intention-to-treat analysis in RCTs.
    El-Masri MM
    Can Nurse; 2015 Apr; 111(3):9. PubMed ID: 25975038
    [No Abstract]   [Full Text] [Related]  

  • 26. What is an intention to treat analysis?
    Cipriani A; Barbui C
    Epidemiol Psichiatr Soc; 2008; 17(1):26-7. PubMed ID: 18444454
    [No Abstract]   [Full Text] [Related]  

  • 27. Cautions as Regulators Move to End Exclusive Reliance on Intention to Treat.
    Hernán MA; Scharfstein D
    Ann Intern Med; 2018 Apr; 168(7):515-516. PubMed ID: 29554689
    [No Abstract]   [Full Text] [Related]  

  • 28. Disentangling estimands and the intention-to-treat principle.
    Leuchs AK; Brandt A; Zinserling J; Benda N
    Pharm Stat; 2017 Jan; 16(1):12-19. PubMed ID: 27910217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intent-to-randomize corrections for missing data resulting from run-in selection bias in clinical trials for chronic conditions.
    Berger VW; Vali B
    J Biopharm Stat; 2011 Mar; 21(2):263-70. PubMed ID: 21391000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strategy for intention to treat analysis in randomised trials with missing outcome data.
    White IR; Horton NJ; Carpenter J; Pocock SJ
    BMJ; 2011 Feb; 342():d40. PubMed ID: 21300711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Making sense of intention-to-treat.
    Sainani KL
    PM R; 2010 Mar; 2(3):209-13. PubMed ID: 20359686
    [No Abstract]   [Full Text] [Related]  

  • 32. The intention-to-treat approach in randomized controlled trials: are authors saying what they do and doing what they say?
    Gravel J; Opatrny L; Shapiro S
    Clin Trials; 2007; 4(4):350-6. PubMed ID: 17848496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intention-to-treat and transparency of related practices in randomized, controlled trials of anti-infectives.
    Beckett RD; Loeser KC; Bowman KR; Towne TG
    BMC Med Res Methodol; 2016 Aug; 16(1):106. PubMed ID: 27557676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correcting for non-compliance in randomized non-inferiority trials with active and placebo control using structural models.
    Wu Y; Zhao L; Hou Y; Li K; Zhou X
    Stat Med; 2015 Mar; 34(6):950-65. PubMed ID: 25534903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Missing data handling in chronic pain trials.
    Kim Y
    J Biopharm Stat; 2011 Mar; 21(2):311-25. PubMed ID: 21391004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Statistical analysis of clinical trials.
    Wassertheil-Smoller S; Kim MY
    Semin Nucl Med; 2010 Sep; 40(5):357-63. PubMed ID: 20674595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intention-to-treat analysis: implications for quantitative and qualitative research.
    Newell DJ
    Int J Epidemiol; 1992 Oct; 21(5):837-41. PubMed ID: 1468842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beyond intention to treat.
    Goetghebeur E; Loeys T
    Epidemiol Rev; 2002; 24(1):85-90. PubMed ID: 12119861
    [No Abstract]   [Full Text] [Related]  

  • 39. Food and Drug Administration guidance on progression-free survival and the intention-to-treat principle.
    Dixon D
    Clin Trials; 2015 Apr; 12(2):179. PubMed ID: 25644996
    [No Abstract]   [Full Text] [Related]  

  • 40. Intention-to-treat analysis: protecting the integrity of randomization.
    Mahaniah KJ; Rao G
    J Fam Pract; 2004 Aug; 53(8):644. PubMed ID: 15298838
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.